Showing results (41-50 of 119) with videos related to
Sort By:
Pageof 12
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|March 17, 2021
Nanostructure-based therapies for liver fibrosisD D Zugravu Pop, D R Mitrea, S Suciu, et al.Melanoma Research|June 1, 1994
HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2)C Scheibenbogen, U Keilholz, J Mytilineos, et al.Cancer Genetics and Cytogenetics|July 1, 1988
Trisomy 4 in two cases of acute myelomonocytic leukemiaS Suciu, H J Weh, R Kuse, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781)B M Czarnetzki, E Macher, S Suciu, et al.The Journal of Urology|February 1, 1986
Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer trials 30761 and 30762H J de Voogt, P H Smith, M Pavone-Macaluso, et al.Blood Cells|January 1, 1982
Scientific basis and criticism of current therapy of acute leukemiaP Stryckmans, A Delforge, D Bron, et al.Acta Physiologica Hungarica|June 1, 2010
Studies on antioxidant effects of the red grapes seed extract from Vitis vinifera, Burgund Mare, Recaş in pregnant ratsAdriana Mureşan, C Alb, S Suciu, et al.Journal of Medicine and Life|July 26, 2016
Credibility judgments in web page design - a brief reviewO Selejan, D F Muresanu, L Popa, et al.British Journal of Haematology|April 8, 1998
Cost-effectiveness and quality-of-life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukemiaC A Uyl-de Groot, B Löwenberg, E Vellenga, et al.European Journal of Cancer & Clinical Oncology|December 1, 1982
Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II studyJ H Mulder, P Dodion, F Cavalli, et al.Pageof 12